Knowtex Turning Scribe into Data Network
Caroline Zhang, CEO of Knowtex, on going from AI medical scribe to AI lab
This turns the scribe from a time saving tool into a data network business. Knowtex is not just drafting notes, it is collecting the full clinical reasoning record, chart context before the visit, the live conversation, and the plan the clinician signs, then using de identified pooled examples to show how similar patients were handled. That creates a workflow edge that free note tools and basic ambient scribes do not have.1 2 3
- In practice, this looks less like a chatbot and more like a doctor seeing a case level benchmark. Before or during a visit, the clinician can pull up patients like mine, filtered by disease, treatment, or demographic, and see what share of similar cases got each care plan. That is closer to peer pattern lookup than static guidelines.1 3
- The raw ingredient is the signed workflow, not just the transcript. Knowtex says it captures chart prep, conversation, codes, orders, follow up steps, and trial routing, with clinicians reviewing and signing outputs. That matters because a network of chosen plans is much more valuable for decision support than a pile of unstructured audio alone.1 3 4
- This is also the bridge to bigger markets. Once a vendor can show what happened for similar patients, it can sell beyond documentation into trial matching, decision support, and pharma research. That is the same broad expansion path seen across the category, as scribes move from note taking into coding, orders, and clinical workflow intelligence.1 2 3 5
The next step is that AI scribe vendors will compete on who has the best closed loop dataset, not who writes the cleanest note. If Knowtex can keep turning signed visits into reliable cross patient patterns, its center of gravity moves toward clinical decision support and research infrastructure, where budgets are larger and the product becomes harder to replace.1 2 3